How to find us
ph./fax: +7 (495) 933-70-40/41
EN
News

17.10.2018
Effective Pharmacovigilance system is the Basis of Safety and Wellbeing of Patients
The first International Conference “PHARMACOVIGILANCE. Challenges and opportunities”, unprecedented in its speakers and content, took place on October 10, 2018 in Moscow. More than 600 experts in the field of drug safety monitoring took part in the Conference. The event was organised by the Federal Service for Surveillance in Healthcare (Roszdravnadzor) and the Association of International Pharmaceutical Manufacturers (AIPM).

19.09.2018
Conference «Pharmacovigilance. Challenges and opportunities» 2018
The Federal Service for Surveillance in Healthcare presents its complements to the Council for International Organizations of Medical Sciences and informs that the conference «Pharmacovigilance. Challenges and opportunities» will take place in Moscow on 10 October 2018.

14.08.2018
X International Conference What Is Happening on the Pharmaceutical Market?
Key event of the autumn is the meeting of the entire pharmaceutical community: manufacturers, distributors, and pharmacies will be held on October 04, 2018 in Moscow.

19.06.2018

Electronic submissions in EAEU & ICH region - current practice & future developments for pharma regulation.


On June 18, 2018 in Moscow the Regulatory Workshop was organized by Eurasian Economic Commission and AIPM & EFPIA with participation (F2F & VC format) of regulatory authorities of EAEU member-states, EU regulators, IT specialists and industry to discuss regulatory aspects, practical implementation issues and road map of eCTD implementation in ICH region & electronic submissions in EAEU region.


19.05.2018
International pharmaceutical industry offers a new level of professional dialogue and partnership
On May 15, 2018 in the frame of Russian Pharmaceutical Forum in St. Petersburg, a press briefing of the Association of International Pharmaceutical Manufacturers (AIPM) was held, entitled “PHARMA 2030: what is needed to develop innovation and attract investment in the pharmaceutical industry in Russia?”.

04.05.2018
THE COMMON MARKET OF MEDICINES WITHIN THE EURASIAN ECONOMIC UNION WAS PRESENTED IN THE EUROPEAN UNION

At the end of April, 2018 the EAEU common market, regulating the circulation of medicines in the Union, was officially presented in Brussels within the framework of the international conference “Regional pharmaceutical markets of the European Union and the Eurasian Economic Union – trends, challenges and best regulatory practices”.


26.02.2018
Vasily Ignatiev, CEO, R-Pharm, became Vice Chairman of the AIPM Board of Directors
February 21, 2018, Moscow – The Association of International Pharmaceutical Manufactures (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Director, Vasily Ignatiev, CEO, R-Pharm, has been elected Vice Chairman of the AIPM Board of Directors.

16.02.2018
Russian Pharmaceutical Forum of Adam Smith Conferences will be taking place in Saint Petersburg on May 15-16, 2018.

Among Forum highlights and hot topics in 2018 will be:

  • Labelling of medicines in Russia
  • GMP inspections
  • State procurement of pharmaceutical drugs: VED list, price setting & the introduction of an information and analytical monitoring and control system
  • Manufacturing of pharmaceutical drugs in Russia: implementation of the import substitution programme in the pharmaceutical industry, obtaining a special investment contract & contract manufacturing
  • Protection of intellectual property rights for pharmaceutical drugs: issues and international practice
  • Search for innovations through partnerships: analysis of opportunities and challenges in the global market
  • Development of a common pharmaceutical market in the EAEU: problems of formation and future prospects
  • Digitalisation in the pharmaceutical industry: prospects for telemedicine and development of innovative medical technologies
  • Changes in the retail market: consolidation of pharmacy chains, prospects for pharmaceutical sales via the Internet and supermarkets and many more!

 

 

Full details about forum are on the website.

 

Quote the VIP code for AIPM members - 1149MAIPM to get a 15% discount upon registration

 

Contact organisers:

Irina Shakhmuratova | +7 495 232 4060 | i.shakhmuratova@adamsmithconferences.com


24.01.2018
Vadim Vlasov was elected as Chairman of the AIPM Board of Directors
January 23, 2018, Moscow – Association of International Pharmaceutical Manufacturers (AIPM) announces that Vadim Vlasov, President of the Novartis Group Russia, Regional Director of Novartis for Eastern and Central Europe and the CIS, was elected to the position of Chairman of the AIPM Board of Directors.

17.01.2018
9th International EAEU & CIS Pharmaceutical Forum
The 9th International EAEU & CIS Pharmaceutical Forum will take place on 27th – 28th February 2018 at Marriott Grand Hotel, Moscow.

17.11.2017
Professional dialogue is a key factor for the successful functioning of EAEU Common market of medicinal products
On November 15, 2017 the Scientific and Practical International Conference “Common market of medicines within the Eurasian Economic Union - modern trends of medicinal products regulation and enforcement”, unprecedented by its participants, content and discussion on high professional level, was held in Moscow. The Conference gathered high-ranking representatives of the Eurasian Economic Commission (EEC), the European Directorate for the Quality of Medicines (EDQM), the European Medicines Agency (EMA), EAEU Pharmacopoeia Committee, regulatory authorities and expert agencies of all EAEU Member-States, heads of the leading national and international professional associations, industry. The event was organized by the Eurasian Economic Commission (EEC), the Association of International Pharmaceutical Manufacturers (AIPM) and the European Federation of Pharmaceutical Industry and Associations (EFPIA).

12.09.2017
14th-15th November 2017 | InterContinental Moscow Tverskaya Hotel
International conference “Clinical Trials in Russia”, November14-15, 2017

29.06.2017
A DIALOGUE BETWEEN REGULATORS AND THE PHARMA INDUSTRY ON MODERN GMP INSPECTION STANDARDS
On June 27, 2017 the Association of International Pharmaceutical Manufacturers (AIPM) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), supported by the State Institute of Medicines and Good Practices of the Russian Ministry of Industry and Trade (SIM & GxP), held a scientific and practical Workshop “Modern tendencies in GMP inspections of pharmaceutical manufacturers”. Representatives of regulatory authorities and expert organizations from Russia and Kazakhstan, representatives of headquarters and Russian branches of international pharmaceutical companies as well as recognized international experts participated in this discussion.

07.04.2017
AIPM welcomes the new member: the international pharmaceutical company CSL Behring has become a member of the Association
On April 7, 2017 – Association of international pharmaceutical manufacturers (AIPM) announces the expansion of its membership. AIPM General Assembly held on April 6, 2017 unanimously decided to include the international pharmaceutical company CSL Behring in the AIPM.

08.02.2017
Russian Pharmaceutical Forum of Adam Smith Conferences
Russian Pharmaceutical Forum will be taking place in Saint Petersburg on May 16-17, 2017. Russian Pharmaceutical Forum 2017 is the foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers. From global strategies to specific operational topics, current situations and development predictions – an in-depth analysis of the situation in the pharma sector in Russia will be presented at the Forum.

19.01.2017
Access Accelerated: Global Initiative to Advance Access to Non-communicable Disease (NCD) Prevention and Care
On 18 January 2017 at the World Economic Forum in Davos, Switzerland, the international pharmaceutical industry launched the first-of-its-kind Global Initiative to advance access to non-communicable disease (NCD) prevention and care in low and lower-middle income countries (LICs and LMICs).

29.12.2016
The leading industry associations have signed a Memorandum of Understanding
December 29, 2016 On December 28, 2016 at the National Medical Chamber a Memorandum of Understanding was officially signed between the leading industry associations of Russia: The National Medical Chamber, represented by President Leonid Roshal; the National Pharmaceutical Chamber, represented by Executive Director Elena Nevolina; the Association of Russian Pharmaceutical Manufacturers, represented by General Director Viktor Dmitriev; the Association of International Pharmaceutical Manufacturers, represented by Executive Director Vladimir Shipkov; the Association “Rosmedprom”, represented by President Yuriy Kalinin; the International Medical Device Manufacturers Association, represented by Executive Director Sergey Kolosov; and National Immunobiological Company represented by General Director Mariam Khubieva.

17.12.2016
PharmaBusiness Summit - 2017
PharmaBusiness Summit-2017 will be held on 14-15 February, 2017, Moscow. The conference is supported by AIPM.

13.12.2016
The 8th International EEU & CIS Pharmaceutical Forum will take place on 28th February – 1st March 2017 at InterContinental Moscow Tverskaya Hotel.
The CIS & EEU Pharmaceutical Forum is the only conference covering the entire CIS pharmaceutical sector. Following detailed research with industry professionals, the Forum’s programme presents a wide and relevant selection of strategic themes.

28.11.2016
EDL “Freezing”: manufacturers and patients need to melt the ice
Last Friday, the press center of ITAR-TASS hosted a press briefing “Ice Age for Patients?”, devoted to the possible suspension of revising of the essential drug list (EDL) and list of drugs to provide certain categories of citizens (ONLS), which was announced by the representatives of the Ministry of Healthcare in the media. Following the meetings of the Commission of the Ministry of Healthcare of Russia on the formation of drug lists, the inclusion into the draft of EDL for 2017 of 24 medicines that have passed expert review and been recommended for inclusion was called into question. Concerned representatives of patient and medical societies, as well as the pharmaceutical industry, invited the Ministry of Healthcare to an open discussion on the burning question.


Ñòðàíèöû: 1 | 2 | 3 | 4 | 5 | 6 | 7
Àðõèâ ïî ãîäàì: 2009; 2010; 2011; 2012; 2013; 2014; 2015; 2016; 2017; 2018;


Version for printing
Members of
AIPM

© AIPM 2018 Ñäåëàíî â Ermine